December 2023

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness  and hope.

Walk In Drive for Matoda

Apitoria Pharma Private Limited (100% subsidary of AUROBINDO PHARMA LTD)

Hiring Candidates for APITORIA PHARMA PRIVATE LIMITED (100% subsidary of Auroblndo Pharma Limited) to fill the following Department in API Division for Pydibheemavaram, Srikakulam.

Quality Control

• Experience : 03 to 07 years
• Qualification : B.Pharmacy /M.Sc
• Relevant experience in handling Microbiology, HPLC & GC.

Kusum Healthcare Pvt. Ltd. is a part of the Kusum group of companies which is a fully integrated, young pharmaceutical group having three manufacturing units; Kusum Healthcare at Bhiwadi Rajasthan, Kusum Healthcare at Indore, Madhya Pradesh in India and Kusum Pharm at Sumy Ukraine. All these manufacturing units are WHO GMP certified and PIC/s compliant.

Looking for candidates for the following openings for our SEZ - Pithampur Plant

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years. 

Torrent Pharma has announced that the United States Food and Drug Administration (USFDA) has conducted the inspection with 5 procedural observations at the Company's Oral-Oncology manufacturing facility situated in Bileshwarpura, Gujarat.

AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data

AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc , a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines using an innovative, protein virus-like particle (VLP) platform.

The ketogenic diet proved to be effective at controlling polycystic kidney disease (PKD) in the first randomized controlled clinical trial of ketogenic metabolic therapy for PKD.

The U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy.

A landmark study led by a King's academic has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects.

The findings from the multinational SHAMAL study, published in The Lancet, demonstrated that 92 per cent of patients using the biologic therapy benralizumab could safely reduce inhaled steroid dose and more than 60 per cent could stop all use.